Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 4, 2023 04:05PM
Cognition Therapeutics (CGTX) Reports FY22, Provides Business Update Mar 23, 2023 07:31AM
Cognition Therapeutics Reports Year End 2022 Financial Results and Provides Business Update Mar 23, 2023 07:30AM
Cognition Therapeutics Reports Year End 2022 Financial Results and Provides Business Update Mar 23, 2023 07:30AM
Cognition Therapeutics Announces Participation in B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference Apr 25, 2022 08:00AM


Apr 25, 2022 08:00AM Cognition Therapeutics Announces Participation in B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
Nov 15, 2021 07:30AM Cognition Therapeutics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in connection with Initial Public Offering
Oct 8, 2021 11:16AM Cognition Therapeutics (CGTX) IPO Opens Fractionally Higher
Oct 8, 2021 07:30AM Cognition Therapeutics, Inc. (CGTX) Prices Upsized 3.77M Share IPO at $12/sh
Oct 8, 2021 07:30AM Cognition Therapeutics Announces Pricing of Upsized Initial Public Offering
Oct 4, 2021 07:57AM Cognition Therapeutics, Inc. (CGTX) Launches 3.35M Share IPO
Oct 4, 2021 07:54AM Cognition Therapeutics Announces Launch of its Initial Public Offering
Jul 19, 2021 07:11AM Cognition Therapeutics, Inc. (CGTX) Files for Up to $50M IPO